Subscribe To

Price Alert Latest News Economic Calendar News

JSPR / Jasper Therapeutics to Present New Positive Data on Briquilimab Conditioning in Patients with Fanconi Anemia at the 2023 Fanconi Anemia Research Fund Scientific Symposium

Jasper Therapeutics to Present New Positive Data on Briquilimab Conditioning in Patients with Fanconi Anemia at the 2023 Fanconi Anemia Research Fund Scientific Symposium

REDWOOD CITY, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on developing novel antibody therapies targeting c-Kit (CD117) to address diseases such as chronic spontaneous urticaria and lower to intermediate risk myelodysplastic syndromes (MDS) as well as novel stem cell transplant conditioning regimes, today announced new positive Phase 1b data on briquilimab as a conditioning agent in the treatment of Fanconi Anemia (FA). Read More

Demo Live Account See Partner Details

Content Topics

Jasper

Therapeutics

Present

Positive

Data

Briquilimab

Conditioning

Patients

Fanconi

Anemia

Research

Scientific

Symposium

Stock

JSPR

Posted: Sep 21 2023, 08:00

Author Name: GlobeNewsWire

JSPR News

By Zacks Investment Research
October 10, 2023

Jasper (JSPR) Up on FDA Nod to Begin Early-Stage Urticaria Study

Jasper (JSPR) announces the FDA clearance to begin the clinical study of briquilimab for chronic spontaneous urticaria. The stock of the company rises

By GlobeNewsWire
September 21, 2023

Jasper Therapeutics to Present New Positive Data on Briquilimab Conditioning in Patients with Fanconi Anemia at the 2023 Fanconi Anemia Research Fund Scientific Symposium

REDWOOD CITY, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (“Jasper”), a biotechnology company focused on d

By PennyStocks
February 17, 2023

Penny Stocks To Buy? 5 With Big News This Week

Penny stocks with big news to watch before next week. The post Penny Stocks To Buy?

By PennyStocks
January 25, 2023

4 Penny Stocks To Watch With Big News This Week

Penny stocks to watch after big news this week. The post 4 Penny Stocks To Watch With Big News This Week appeared first on Penny Stocks to Buy, Picks,

By InvestorPlace
January 13, 2023

Why Is Jasper Therapeutics (JSPR) Stock Up 50% Today?

There's no denying that Jasper Therapeutics (NASDAQ: JSPR ) stock investors are in a good mood today. They're clearly celebrating the announcement of

By Market Watch
January 3, 2023

Jasper Therapeutics shares jump after announcing new clinical data

Shares of Jasper Therapeutics Inc. JSPR, +318.31% soared 283% in trading on Tuesday after the company said in a news release that its experimental the

By GlobeNewsWire
June 23, 2022

Jasper Therapeutics to Present at the LifeSci Partners 2nd Annual Genetic Medicines Symposium

REDWOOD CITY, Calif., June 23, 2022 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on enabling cures wi

By GlobeNewsWire
March 31, 2022

Jasper Therapeutics to Present Updated Data on JSP191 Conditioning in SCID Patients at the 2022 Clinical Immunology Society Annual Meeting

REDWOOD CITY, Calif., March 31, 2022 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on hematopoietic ce

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.